Results
1 -
10 of
14
(Click
here to explore results)
- Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics, CHAPTER 5 Reptile Venoms as a Platform for Drug Development. Ryan J. R. McCleary, Tse S. Kang, R. Manjunatha Kini
, 2015
, Pages 129-162
- Peptide-based Drug Discovery: Challenges and New Therapeutics, CHAPTER 2 Identification and Validation of Peptide Therapeutic Targets and Indications. Andrew A. Young
, 2017
, Pages 35-75
- Organic Chemistry of Drug Degradation, CHAPTER 4 Various Types and Mechanisms of Degradation Reactions
, 2012
, Pages 110-149
- Chemistry, Biological Activities and Therapeutic Applications of Medicinal Plants in Ayurveda, Chapter 13 Ayurvedic Knowledge Inspired Approach to Modern Drug Discovery. Premalatha Balachandran
, 2023
, Pages 325-373
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 8 COVID-19 Interventional and Therapeutic Clinical Trials: Small Molecules, Interactions, Outcomes and Opportunities. Edward Croom, Fengyu Zhang, Claude Hughes
, 2022
, Volume 2
, Pages 221-242
- Polysaccharide-based Biomaterials: Delivery of Therapeutics and Biomedical Applications, Chapter 4 Chitosan-based Nanocarriers for Drug Delivery: Advances and Challenges. D. M. dos Santos, C. A. S. Ballesteros, A. Grizzo, V. P. V. da Costa, A. D. Alvarenga, P. A. M. Chagas, D. S. CorrĂȘa
, 2023
, Pages 90-125
- Venoms to Drugs: Venom as a Source for the Development of Human Therapeutics, Subject Index
, 2015
, Pages 306-320
- Acute Brain Impairment: Scientific Discoveries and Translational Research, Chapter 8 Combined DrugâDiagnostic Test Co-development for Predicting and Preventing Brain Impairments. Galina Izykenova, Shean Phelps
, 2018
, Pages 128-140
- Pharmaceutical Salts and Co-crystals, Chapter 13 Limits of the Co-crystal Concept and Beyond. Gerard Coquerel
, 2012
, Pages 300-317
- Amino Acids, Peptides and Proteins: Volume 25, Analogue and conformational studies on peptide hormones and other biologically active peptides. J. S. Davies, C. M. Bladon
, 1994
, Volume 25
, Pages 155-245